Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Peripheral blood mutated p53 DNA and its clinical value in human breast cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology] - 1 Mar 2003

Di Gen-hong, Liu Gang, Wu Jiong, Shen Zhen-zhou, Shao Zhi-min

Abstract excerpt

OBJECTIVE: To evaluate the clinical value of mutated p53 in the peripheral blood of breast cancer patients. METHODS: Plasma DNA of 126 breast cancer patients and 92 healthy women was examined. DNA extraction from the tumor and tissue samples was performed by a nonorganic method. Plasma DNA was purified on Qiagen columns. PCR-SSCP analysis was performed to examine the point mutations in the conserved exons 5, 6, 7...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Aged
Share to Carcinoembryonic Antigen

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mucin-1

Share to Mutation

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12795838

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Peripheral blood mutated p53 DNA and its clinical value in human breast cancer].PMID 12795838Read ↗

p53 mutation in plasma DNA and its prognostic value in breast cancer patients.Semantic proximity Read ↗

TP53 gene mutations in plasma DNA of cancer patients.Semantic proximity Read ↗

Clinical factors associated with circulating tumor <scp>DNA</scp> (ct<scp>DNA</scp>) in primary breast cancerSemantic proximity Read ↗

Tumor-specific DNA in plasma of breast cancer patients.Semantic proximity Read ↗

[Clinical value of gene diagnosis in breast cancer].Semantic proximity Read ↗

Prognostic value of p53 molecular status in high-risk primary breast cancer.Semantic proximity Read ↗

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.Semantic proximity Read ↗

TP53 gene in blood plasma DNA of tumor patients.Semantic proximity Read ↗

[Clinical significance of p53 antibody].Semantic proximity Read ↗

Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.Semantic proximity Read ↗

The p53 Gene in Breast Cancer: Prognostic Value of Complementary DNA Sequencing Versus ImmunohistochemistrySemantic proximity Read ↗

[The methodological specificity of PCR-test of gene p53 in plasma and blood cell DNA of oncological patients].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.